S5 - E3.1 - Why create a new MASLD nomenclature?
Send us a text This conversation focuses on the issues and visions that led to the identified need for a new MASLD nomenclature. Maru Rinella and Jeff Lazarus discuss the original goals of the process and how focus broadened and shifted throughout. It starts with Maru Rinella describing what she terms “an existential crisis” for the field around a publication suggesting changing the name of the disease from “non-alcoholic” fatty liver disease to “metabolic” fatty liver disease. She considers...
26 Helmi 202410min
S5 - E3 - The New MASLD Nomenclature And How We Got Here
Send us a text The process of creating a new MASLD nomenclature for the condition formerly known as Fatty Liver Disease was a multi-year process with unique challenges and complications. Three leaders in the process, Maru Rinella, Jeff Lazarus and Meena Bansal, and patient advocate Mike Betel join Louise Campbell and Roger Green to discuss the process, transition and rollout. 00:00:00 - Surf's Up: Season 5 Episode 3 Co-hosts Louise Campbell and Roger Green sit with Maru Rinella, who co-chair...
24 Helmi 202459min
S5 - E2.5 - Conversations From The Vault: Jeff McIntyre On ICER Reviews And NITs
Send us a text This conversation is part of a March, 2023 interview between co-hosts Louise Campbell and Roger Green and Jeff McIntyre of Global Liver Institute, one of the guests on the S5 E2 panel. This particular conversation focuses largely on Jeff’s insights around the imminent anticipated drug approvals of obeticholic acid (which was withdrawn several months later) and resmetirom (whose PDUFA date is next month). Jeff's analysis includes mixed levels of enthusiasm around a draft repor...
19 Helmi 202414min
S5 - E2.4 - MASLD Patient Advocates' Priority 2024 MASH Programs
Send us a text Leading MASLD patient advocates Jeff McIntyre (Global Liver Institute), Milan Mishkovikj (European Liver Patients Association), Tony Villiotti (NASH kNOWledge) and Wayne Eskridge (Fatty Liver Foundation) describe their respective organizations' priority 2024 MASH programs to co-hosts Louise Campbell and Roger Green. In this conversation, the advocates each describe their respective organizations' top project for 2024. Wayne Eskridge goes first, describing the Fatty Liver Foun...
18 Helmi 202415min
S5 - E2.3 - Where Do MASLD Patients And Advocates Fit In MASH Drug Access Decisions?
Send us a text Leading MASLD patient advocates Jeff McIntyre (Global Liver Institute), Milan Mishkovikj (European Liver Patients Association), Tony Villiotti (NASH kNOWledge) and Wayne Eskridge (Fatty Liver Foundation) join Louise Campbell and Roger Green to explore the roles advocacy groups might play in supporting patient access through drug information, education and advocacy processes. The conversation starts with Roger. He takes note of advocates' sense that they are held outside ...
17 Helmi 202413min
S5 - E2.2 - After The First MASH Drug Approval, Focus Shifts To Patient Access
Send us a text Leading patient advocates Jeff McIntyre (Global Liver Institute), Milan Mishkovikj (European Liver Patients Association), Tony Villiotti (NASH kNOWledge) and Wayne Eskridge (Fatty Liver Foundation) join Louise Campbell and Roger Green to discuss what Jeff calls "the second half" - the hard work on coding and patient access that will follow the first MASH drug approval.
17 Helmi 202414min
S5 - E2.1 - Expectations For The Resmetirom PDUFA Date - The First MASH Drug Approval?
Send us a text Leading patient advocates Jeff McIntyre (Global Liver Institute), Milan Mishkovikj (European Liver Patients Association), Tony Villiotti (NASH kNOWledge) and Wayne Eskridge (Fatty Liver Foundation) discuss their expectations for life after the resmetirom PDUFA data and, with it, the potential for the first MASH drug approval, with Louise Campbell and Roger Green. The conversation starts with Roger noting a funny coincidence; the March 14 PDUFA data for resmetirom is Pi D...
17 Helmi 202413min
S5 - E02 - MASLD Patient Advocates Plan MASH Activities For 2024
Send us a text 00:00:00 Surf's Up: Season 5 Episode 2 Co-hosts Louise Campbell and Roger Green sit with four leading MASLD patient advocates (Tony Villiotti of NASH kNOWledge, Wayne Eskridge of the Fatty Liver Foundation, Jeff McIntyre of the Global Liver Institute, and Milan Mishkevikj of the European Liver Patients Association) to discuss their plans and actions for MASH patients in 2024. The discussion covers the advocates' hopes and concerns for the year and the programs and effort...
15 Helmi 20241h 6min
